Palmer, James N 235 Pan, Quintin 239 Park, Ben-Ho 68, 129 Park, Jong-In 238 Patz, Samuel 239 Pauly, John L 230, 234 Peacock, Craig D 240 Pearlman, Justin D 231 Pearse, David B 239 Peters, Edward 231 Petrache, Irina 235 Petty, Thomas L 232 Pili, Roberto 230 Potter, David A 234 Powell, Jonathan D 235 Prakash, Y. S 239 Pritsos, Chris A 239 Prokhorov, Alexander V 235 Rade, Jeffrey 40 Raman, Venu 231, 235 Ratner, Adam J 237 Ratovitski, Edward 234, 240 Rechavi, Gideon 31, 32, 34, 285 Redberg, Rita 26, 29, 255, 258 Reisman, David N 234 Repace, James 230 Reynolds, Paul R 238 Rhee, Sang Hoon 238 Rigotti, Nancy 230, 235, 240 Robbins, Richard A 231 Rocco, James W 232 Rodriguez, Ronald 230 Rogers, Richard J 141 Rosen, Laura 240 Rosser, Charles J 239 Rudek, Michelle A 35, 38, 82, 113, 256, 261, 275 Rudin, Charles M 35, 36, 113, 121, 232, 233, 240, 257, 261, 275 Saha, Debabrata 231, 239 Salihu, Hamisu M 231 Samet, Jonathan 232 Schlosser, Rodney J 235 Schouenborg, Jens 234 Seagrave, JeanClare 234 Sebrié, Ernesto 240 Selaru, Florin M 240 Serafini, Paolo 240 Shachaf, Catherine M 233 Shams, Homayoun 235 Shapiro, Steven D 235 Sharma, Sanjai 238 Shim, Yun M 234 Shusterman, Dennis 238 Sidhaye, Venkataramana 240 Sidransky, David 3, 13 Siegel, Michael B 230 Singh, Anju 238 Singh, Bhuvanesh 235 Singh, Shashibushan P 198 Slingerland, Joyce 237 Soldin, Offie P 235, 240 Spanier, Adam 238 Spitz, Margaret R 223 Springer, Matthew L 239 Srisuma, Sorachai 236 Stabile, Laura A 233 Starcher, Barry 232 Stearman, Robert S 232 Stewart, Michael 47 Stillman, Frances 40 Stroud, Laura 237 Su, Yunchao 232, 239 Subbaramaiah, Kotha 47 Suddereth, Leisa 229 Switzer, Paul 231 Tanski, Susanne E 45 Taraseviciene-Stewart, Laimute 239 Taylor, Rodney J 237 Teret, Stephen P 232 Tesfaigzi, Yohannes 237 Travers, Mark J 236 Trink, Barry 231, 237 Turino, Gerald 234 Tyagi, Shivraj 239 Valacchi, Giuseppe 237 van der Vliet, Albert 239 Van Winkle, Laura S 237 Vandivier, R. William 237 Vassallo, Robert 234 Vigodner, Margarita 240 Vincek, Vladimir 234 Wadler, Scott 232 Walter, Robert E 231 Wang, Hong-Gang 237 Watkins, D. Neil 230 Watkins, D. Neil, 230 Weitzman, Michael 45 Wilder, Julie A 235 Wilk, Jemma B 234 Wilson, Andrew A 238 Winickoff, Jonathan P 231, 239 Wolf, Jeffrey S 232 Wong, Brian J. F 231, 237 Wong, Kwok-Kin 234 Wong, Richard J 232, 237 Woodworth, Bradford A 240 Wu, Wenxin 154 Xiao, Lei 230 Xing, Michael M 134 Yang, Jun 234 Yankelevitz, David F 46, 47, 122, 264 Yedgar, Saul 238 Yolton, Kimberly 237 Young, Patricia L 13, 228 Yu, Jian 233 Zahnow, Cynthia 233, 239 Zemans, Rachel L 240 Zhai, Rihong 238 Zhang, Jianliang 233, 237 Zhang, Jin 233 Zhao, Feng 238 Zheng, Yun-Ling 234 Zhou, Qun 240 Zhou, Wei 233 2 9 0 P A G E
APPENDICES: INDEX BY SUBJECT Acute Lung Injury 48, 100, 104, 237, 248, 254, 268, 278, 291 Airway Diseases 48, 54, 56, 291 Arthritis 38, 57, 209, 232, 240, 262, 267, 272, 291 Author Index 291 Blissard, Lani 13, 228, 288, 291 Board Designated Awards 14, 291 Cahan, William 2, 14, 216, 223, 242 Cancer, Bladder 18, 19, 58, 59, 60, 61, 62, 63, 64, 96, 97, 98, 167, 230, 234, 235, 236, 237, 238, 239, 240, 248, 251, 252, 256, 258, 267, 272 Cancer, Breast 19, 37, 59, 63, 64, 65, 66, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 124, 128, 129, 191, 230, 231, 233, 234, 235, 236, 237, 238, 239, 240, 242, 250, 251, 252, 259, 270, 271, 278, 279, 284, 287 Cancer, Cervical 19, 82, 83, 236, 248 Cancer, Chemotherapeutic Agents 58, 291 Cancer, Gastric 84, 240 Cancer, Head and Neck 13, 31, 34, 63, 81, 84, 85, 86, 87, 88, 89, 90, 91, 93, 94, 95, 96, 97, 107, 184, 230, 231, 232, 234, 237, 238, 239, 240, 242, 245, 251, 254, 262, 264, 265, 271, 272, 274, 275, 277, 278, 280, 291 Cancer, Kidney 97, 98, 231, 246, 248, 252 Cancer, Lung 30, 31, 32, 33, 34, 35, 36, 38, 39, 46, 47, 49, 63, 77, 78, 91, 92, 95, 98, 99, 100, 101, 102, 103, 104, 105, 107, 108, 109, 110, 111, 112, 113, 114, 115, 117, 118, 119, 120, 121, 122 Cancer, Lymphoma 12, 37, 107, 121, 124, 125, 230, 291 Cancer, Multiple 125, 130, 291 Cancer, Ovarian 131, 235, 291 Cancer, Prostate 19, 37, 63, 66, 119, 130, 131, 132, 133, 134, 167, 238, 239, 246, 248, 254, 263, 272, 291 Cancer, Thyroid 81, 85, 88, 94, 126, 128, 134, 135, 232, 258, 259, 265, 266, 273, 275, 281, 285, 291 Cardiovascular 12, 16, 17, 25, 26, 28, 46, 47, 54, 135, 136, 137, 138, 140, 141, 143, 165, 174, 189, 196, 197, 205, 206, 214, 215, 216, 217, 218, 226, 228, 230, 231, 233, 234, 235, 240, 246, 252, 255, 256, 265, 273, 291 Chronic Kidney Disease 143, 144, 206, 238, 291 Commonly Used Acronyms 291 COPD 20, 21, 22, 25, 26, 27, 28, 36, 46, 49, 50, 55, 100, 112, 144, 145, 146, 147, 148, 149, 150, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 165, 193, 200, 213, 222, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 244, 247, 252, 253, 254, 261, 266, 267, 271, 280, 281, 282, 291 Davis, Ronald M 235, 288, 291 Diagnostic Techniques 102, 162, 164, 229, 291 Disease Prevention 12, 41, 167, 175, 217, 291 Distinguished Professors †160, 216, 291 Education 14, 17, 25, 29, 30, 41, 44, 45, 47, 167, 176, 181, 217, 219, 222, 226, 228, 233, 235, 240, 291 Expanding Grantees Research Capabilities Through Preservation of Tobacco Disease Documents 177, 291 Exposure to Second Hand Tobacco Smoke 12, 14, 17, 45, 117, 136, 172, 178, 188, 202, 229, 231, 233, 234, 236, 291 FAMRI Award Categories 14, 291 FAMRI Centers of Excellence 25, 44, 291 FAMRI Grantee Portal 227, 291 FAMRI Supported Publications and Meeting Abstracts 291 Geographic Distribution 15, 291 Highlighted Research 291 Hormonal Changes from Tobacco Exposure 189, 291 Immune Function Impacted by Tobacco Smoke 191, 194, 291 Infectious Diseases 50, 194, 195, 291 Lane, Bland 13, 14, 25, 29, 44, 216, 228, 229, 230, 238, 242, 289, 291 List of FAMRI Grantees 230, 231, 232, 233, 235, 236, 238, 240, 291 Menopause 21, 65, 195, 235, 253, 291 Neurobehavioral Consequences of Tobacco Exposure 195, 196, 291 Peer Reviewed Awards 14, 291 Personal Thoughts from the Flight Attendant Members of the Board of Trustees 228, 291 Pregnancy and Perinatal Effects from Tobacco Exposure 197, 204, 291 Research Summaries 291 Richmond, Julius B 2, 12, 13, 41, 44, 187, 217, 235, 265, 291 Sinusitis 23, 154, 181, 183, 205, 206, 207, 208, 209, 210, 211, 212, 217, 222, 231, 232, 233, 237, 238, 240, 291 Skin and Second Hand Smoke 212, 291 Spermatogenesis 22, 213, 291 Suddereth, Leisa 229, 290, 291 Vision 3, 36, 214, 215, 264, 291 Young, Patricia L 13, 228, 290, 291 P A G E 2 9 1
- Page 3 and 4:
MISSION FAMRI is an Independent Not
- Page 5 and 6:
FOREWORD David Sidransky, MD, Vice-
- Page 7 and 8:
FAMRI CENTERS OF EXCELLENCE........
- Page 9 and 10:
PAI-1 And Airway Remodeling In Seco
- Page 11 and 12:
Promoter Hypermethylation As A Mole
- Page 13 and 14:
Expression Profiling Of Blood In Lu
- Page 15 and 16:
Inhibition Of Hedgehog Signaling By
- Page 17 and 18:
Genetic Epidemiology Of Pulmonary F
- Page 19 and 20:
Reducing Second Hand Tobacco Smoke
- Page 21 and 22:
SINUSITIS .........................
- Page 24 and 25:
INTRODUCTION David M. Burns, MD, Pr
- Page 26 and 27:
FAMRI AWARD CATEGORIES The Board of
- Page 28 and 29:
HIGHLIGHTED FAMRI FUNDED RESEARCH C
- Page 30 and 31:
Xia L, Crane-Godreau M, Deng B, Lei
- Page 32 and 33:
Farassati F, Yang A-D, Lee P WK. On
- Page 34 and 35:
Nicotine & Tobacco Research 2007;9:
- Page 36 and 37:
homes where smoking is banned are m
- Page 38 and 39:
a survey-based COPD severity score.
- Page 40 and 41:
allergic rhinitis have increased re
- Page 42 and 43:
However, while the economic costs a
- Page 44 and 45:
mitochondrial adenosine diphosphate
- Page 46 and 47:
CHR, and CDE. The promoter architec
- Page 48 and 49:
Trends Mol Medicine 2007;13:150-157
- Page 50 and 51:
was also demonstrated to be effecti
- Page 52 and 53:
and are currently in clinical testi
- Page 54 and 55:
Academic Societies’ Meeting. Hono
- Page 56 and 57:
acceptability, and usefulness of us
- Page 58 and 59:
utilize telephone conference call f
- Page 60 and 61:
FAMRI-FUNDED RESEARCH COMBATING EFF
- Page 62 and 63:
act via limited proteolysis of subs
- Page 64 and 65:
was significantly higher in Nic:RSV
- Page 66 and 67:
presenting cells (APC) in vitro; an
- Page 68 and 69:
FAMRI Supported Publications Collac
- Page 70 and 71:
nisms of combostatin and its parent
- Page 72 and 73:
Bladder cancer progression involves
- Page 74 and 75:
45, NPV = 8%), 3 months (n = 42, NP
- Page 76 and 77:
THE EFFECT OF ADENYLATE KINASE 3 ON
- Page 78 and 79:
Agency report in 2006 (ftp://ftp.ar
- Page 80 and 81:
Narayan S, Jaiswal AS. Structure-ba
- Page 82 and 83:
in the duration of the cigarette sm
- Page 84 and 85:
ENVIRONMENTAL AND GENETIC RISK FACT
- Page 86 and 87:
Estrogen activates the cell cycle b
- Page 88 and 89:
Schaeffer MW, Sinha Roy S, Mukherje
- Page 90 and 91:
east tumors. When breast cancer cel
- Page 92 and 93:
is to identify and characterize key
- Page 94 and 95:
of these target genes are regulated
- Page 96 and 97:
CANCER, GASTRIC CURRENT RESEARCH GA
- Page 98 and 99:
CANCER, HEAD AND NECK CURRENT RESEA
- Page 100 and 101:
Tran HM, Shi G, Li G, Carney JP, O
- Page 102 and 103:
ANALYSIS OF SERUM PEPTIDES ASSOCIAT
- Page 104 and 105:
(BE), gastroesophageal reflux disea
- Page 106 and 107:
CANCER, HEAD AND NECK COMPLETED RES
- Page 108 and 109:
in normal epithelia, was shown to b
- Page 110 and 111:
Commentary: Bonn, D. Urine test for
- Page 112 and 113:
disease (COPD), innate immune dysfu
- Page 114 and 115:
SCLC. The foundation for this appro
- Page 116 and 117:
Witta SE, Gemmill RM, Hirsch FR, Co
- Page 118 and 119:
MYC-induced lymphomagenesis. It wil
- Page 120 and 121:
PUMA Mediates Intestinal Apoptosis
- Page 122 and 123:
leomycin-induced pulmonary fibrosis
- Page 124 and 125:
dimensional magnetic resonance micr
- Page 126 and 127:
vaccine, Ad.p53-DC, was well tolera
- Page 128 and 129:
esults of these studies should also
- Page 130 and 131:
prostaglandin E2 in non-small-cell
- Page 132 and 133:
were sequenced from NSCLC tissue an
- Page 134 and 135:
expression has a protective effect
- Page 136 and 137:
evaluate the expression level of Id
- Page 138 and 139:
as a target for the sensitization o
- Page 140 and 141:
Cancer Biol Ther 2006;5(1):48-53. A
- Page 142 and 143:
REGULATION OF TGF BETA SIGNALING IN
- Page 144 and 145:
among men exposed to cigarette smok
- Page 146 and 147:
FAMRI Supported Publications Gibbs
- Page 148 and 149:
or 500 ppm CO for 30 days. Blood pr
- Page 150 and 151:
adiponectin signals through activat
- Page 152 and 153:
CARDIOVASCULAR COMPLETED RESEARCH S
- Page 154 and 155:
EFFECTS OF SECOND HAND TOBACCO SMOK
- Page 156 and 157:
nicotine administration in vivo on
- Page 158 and 159:
degradation of type III collagen in
- Page 160 and 161:
wild-type (WT) mice and mice geneti
- Page 162 and 163:
REDUCED NEUTROPHIL DEATH IN TOBACCO
- Page 164 and 165:
H 2 O 2 -induced nuclear fragmentat
- Page 166 and 167:
The aims of this study are: 1) to d
- Page 168 and 169:
tion (GWA) studies of quantitative
- Page 170 and 171:
propagation of emphysema by alveola
- Page 172 and 173:
duced mainly by alveolar type-II ep
- Page 174 and 175:
concentrations of inflammatory indi
- Page 176 and 177:
subglottis. Arch Otolaryngol Head N
- Page 178 and 179:
detector row CT (MDCT), 2005. Prese
- Page 180 and 181:
of smoke-free homes: findings from
- Page 182 and 183:
Travers MJ, Hyland A. Wisconsin Air
- Page 184 and 185:
understood there would be several v
- Page 186 and 187:
Travers MJ, Cummings KM, Repace JL,
- Page 188 and 189:
REDUCING SHS: CARDIAC AND ASTHMA OU
- Page 190 and 191:
tobacco companies fought tobacco co
- Page 192 and 193:
consumer acceptance through Web-bas
- Page 194 and 195:
housing, there is a need for scient
- Page 196 and 197:
youth to magazine tobacco advertisi
- Page 198 and 199:
Stukel JM, Heys JJ, Caplan MR. Opti
- Page 200 and 201:
EXPOSURE TO SECOND HAND TOBACCO SMO
- Page 202 and 203:
aldosterone, cortisol, corticostero
- Page 204 and 205:
the expression of numerous genes th
- Page 206 and 207:
and signaling functions), is suppre
- Page 208 and 209:
development and behavior, from the
- Page 210 and 211:
dams exposed to 75 ppm (1 pack/day)
- Page 212 and 213:
Poster Presentation at the 11th Int
- Page 214 and 215:
inhibition among Blacks and Whites.
- Page 216 and 217:
tobacco exposure (biologic measures
- Page 218 and 219:
ularly true for the chemokine GRO-a
- Page 220 and 221:
EPITHELIUM AND IMMUNOMODULATION IN
- Page 222 and 223:
patency was best assessed using hig
- Page 224 and 225:
significant increases in sinusitis
- Page 226 and 227:
VISION ONGOING RESEARCH GENE PROFIL
- Page 228 and 229:
FAMRI DISTINGUISHED PROFESSORS FAMR
- Page 230 and 231:
is a strong motivator for smoking c
- Page 232 and 233:
egulations and attitudes towards th
- Page 234 and 235:
y the tobacco industry of the harmf
- Page 236 and 237:
epair capacity assays. Her collabor
- Page 238 and 239:
Society for Research on Nicotine an
- Page 240 and 241:
PERSONAL THOUGHTS FROM THE FLIGHT A
- Page 242 and 243:
APPENDICES: LIST OF FAMRI GRANTEES
- Page 244 and 245:
BDA Butter, Karen A., MLS Universit
- Page 246 and 247:
AWARD INVESTIGATOR INSTITUTION TITL
- Page 248 and 249:
AWARD INVESTIGATOR INSTITUTION TITL
- Page 250 and 251:
AWARD INVESTIGATOR INSTITUTION TITL
- Page 252 and 253: AWARD INVESTIGATOR INSTITUTION TITL
- Page 254 and 255: APPENDICES: ACRONYMS The following
- Page 256 and 257: apoptosis. COPD. c2008;5:153-162. A
- Page 258 and 259: KW, Lengauer C. Identification of c
- Page 260 and 261: Brait M, Begum S, Carvalho AL, Dasg
- Page 262 and 263: Measuring disease-specific quality
- Page 264 and 265: Mukherjee M, Schuldenfrei A, Kowals
- Page 266 and 267: sion attenuates cigarette smoke- or
- Page 268 and 269: Kuck J, Bauer JA. Racial difference
- Page 270 and 271: 2008;26:856-862. Helfrich BA, Raben
- Page 272 and 273: acute nephritis. Am J Nephrol 2008
- Page 274 and 275: O’Malley BW. Double DNA repair hi
- Page 276 and 277: of base excision repair pathways. C
- Page 278 and 279: virotherapy of anaplastic thyroid c
- Page 280 and 281: Marsit CJ, Posner MR, McClean MD, K
- Page 282 and 283: 2008. Mukhopadhyay S, Mukherjee S,
- Page 284 and 285: Pache JC, Burton DW, Deftos LJ, Has
- Page 286 and 287: 2004;114:1248-1259. Rangasamy T, Gu
- Page 288 and 289: Childhood pregnancy (10-14 years ol
- Page 290 and 291: J Public Health 2004;94:1959-1964.
- Page 292 and 293: 2007;67(11):5337-5344. Sullivan AK,
- Page 294 and 295: 2005;90:5265-5269. Vassallo R, Kroe
- Page 296 and 297: Fong Y. Effective treatment of head
- Page 298 and 299: apoptosis control. Biochem Biophys
- Page 300 and 301: APPENDICES: INDEX BY AUTHOR Abdulla
- Page 304 and 305: NOTES: 2 9 2 P A G E
- Page 306: ATTRIBUTION FLIGHT ATTENDANT MEDICA